Literature DB >> 17061160

Endoscopically removed hepatolithiasis associated with cavernous transformation of the portal vein and antiphospholipid antibody syndrome.

Keisuke Okudaira1, Atsushi Kawaguchi, Takuya Inoue, Kazutoshi Hashiguchi, Yoshikazu Tsuzuki, Shigeaki Nagao, Kazuro Itoh, Soichiro Miura.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17061160     DOI： 10.1007/s10620-005-9059-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  18 in total

Review 1.  Antiphospholipid antibodies and thrombosis.

Authors:  M Greaves
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

2.  Superior mesenteric artery thrombosis associated with antiphospholipid syndrome.

Authors:  M E Hamilton
Journal:  West J Med       Date:  1991-08

3.  Portal and mesenteric vein and inferior vena cava thrombosis associated with antiphospholipid syndrome.

Authors:  M Higa; M Kojima; S Ohnuma; S Hamanaka; W Yamamuro; H Sugiura; M Sato
Journal:  Intern Med       Date:  2001-12       Impact factor: 1.271

4.  Increased biliary group II phospholipase A2 and altered gallbladder bile in patients with multiple cholesterol stones.

Authors:  J Shoda; T Ueda; T Ikegami; Y Matsuzaki; S Satoh; M Kano; K Matsuura; N Tanaka
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

5.  The effect of decreased portal blood flow on the biliary system.

Authors:  Y Saji
Journal:  Jpn J Surg       Date:  1988-09

6.  A clinicopathological study on intrahepatic cholesterol gallstones.

Authors:  T Akiyama; T Nagakawa; M Kanno; T Ohta; K Ueno; Y Higashino; I Konishi; I Miyazaki; M Uogishi; H Sodani
Journal:  Jpn J Surg       Date:  1990-09

7.  Anticardiolipin antibodies in patients with infectious diseases.

Authors:  M B Santiago; W Cossermelli; M F Tuma; M N Pinto; R M Oliveira
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

8.  Mesenteric and portal venous obstruction associated with primary antiphospholipid antibody syndrome.

Authors:  H J Lee; J W Park; J C Chang
Journal:  J Gastroenterol Hepatol       Date:  1997-12       Impact factor: 4.029

Review 9.  Anticardiolipin antibodies and thrombosis.

Authors:  R L Bick; W F Baker
Journal:  Hematol Oncol Clin North Am       Date:  1992-12       Impact factor: 3.722

10.  The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels.

Authors:  Y Bayraktar; F Balkanci; A Ozenc; S Arslan; T Koseoglu; A Ozdemir; B Uzunalimoglu; H Telatar; A Gurakar; D H Van Thiel
Journal:  Am J Gastroenterol       Date:  1995-11       Impact factor: 10.864
View more
  3 in total

1.  Surgical management of hepatolithiasis.

Authors:  Sujit Vijay Sakpal; Nitin Babel; Ronald Scott Chamberlain
Journal:  HPB (Oxford)       Date:  2009-05       Impact factor: 3.647

Review 2.  Four Major Factors Contributing to Intrahepatic Stones.

Authors:  Xi Ran; Baobing Yin; Baojin Ma
Journal:  Gastroenterol Res Pract       Date:  2017-01-09       Impact factor: 2.260

Review 3.  Step-by-step strategy in the management of residual hepatolithiasis using post-operative cholangioscopy.

Authors:  Xu-Dong Wen; Tao Wang; Zhu Huang; Hong-Jian Zhang; Bing-Yin Zhang; Li-Jun Tang; Wei-Hui Liu
Journal:  Therap Adv Gastroenterol       Date:  2017-09-21       Impact factor: 4.409
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.